Check out an interview with our CEO, Chris Savile, where he provides some additional information on our Q2 results and outlook for the rest of 2024.
https://t.co/oWlhZQA50f
We're excited to announce another new, large partnership that extends our technology platform to the production of biopesticides. This partnership brings both significant near-term R&D revenue and long-term upside.
https://t.co/n2K6w55YRl
Sorry, we're a bit behind on our posts. If you haven't read it yet, here's the recent PR announcing our large partnership with Laurus Labs.
https://t.co/gSrwNytxFf
@WillowBio is very pleased to announce the signing of a Master Service Agreement with @KalsecInc for the development and manufacture of functional food ingredients, using the FutureGrown precision fermentation platform.
https://t.co/RP4sR2o3b2
@FoodNavigatorUS discussed @WillowBio's recently announced project, astaxanthin, with our CEO Dr. Peter Seufer-Wasserthal.
Willow Biosciences bids for slice of astaxanthin market with precision fermentation tech breakthrough https://t.co/H4s6rCWpdi
@willowbio announces the addition of a new pure, consistent and sustainable functional ingredient; FutureGrown Astaxanthin. This carotenoid is used in animal feed as a pigment, and in cosmetics & nutraceuticals for its powerful antioxidant properties.
https://t.co/6ymzCVonve
Biden’s executive order advancing biotech signals a promising future for the industry. At Willow, we have been working towards providing pure, consistent & sustainable functional ingredients since 2019, and we are proud to be a part of the Bio Revolution.
https://t.co/eVREovZhHw
Willow Biosciences completes Q2 with significant progress to its operational platform, leadership and liquidity. Read more in our press release.
#FutureGrown#SynBio#Biosynthesis
https://t.co/pDnojZ4hyP
Next week, Willow is attending IFT first, the premier B2B #foodtech expo in Chicago. Looking forward to discussing functional ingredients and Willow's own sustainable #FutureGrown platform.
#biotech#natural#SynBio
Willow has incorporated Inscripta's Onyx Genome Engineering Platform into its strain engineering workflows. Read more in our press release here.
#FutureGrown#SynBio
https://t.co/VTnnctW8xr
Willow expands its portfolio with a new partnered pharmaceutical project demonstrating the wide array of opportunities accessible to Willow’s #FutureGrown technology platform.
https://t.co/z7Gx7SAv6c
$WLLW Willow Biosciences strikes manufacturing partnership to boost production capacity for its cannabinoid products https://t.co/uLUdVWsaeY @WillowBio $CANSF #WLLW#CANSF
Come visit us at New York Society of Cosmetic Chemists Supplier’s Day, May 3-4 in New York City’s Javits Convention Center – booth 459
https://t.co/Qe5tvV4BI0